First Time Loading...

Metropolis Healthcare Ltd
NSE:METROPOLIS

Watchlist Manager
Metropolis Healthcare Ltd Logo
Metropolis Healthcare Ltd
NSE:METROPOLIS
Watchlist
Price: 1 793.5 INR -0.75% Market Closed
Updated: May 8, 2024
Section:
 

Relative Value

The Relative Value of one METROPOLIS stock under the Base Case scenario is 1 931.25 INR. Compared to the current market price of 1 793.5 INR, Metropolis Healthcare Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

METROPOLIS Relative Value
Base Case
1 931.25 INR
Undervaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.9
P/S
P/S
Price to Sales
7.9
vs History
47
vs Industry
18
Median 3Y
7.5
Median 5Y
7.7
Industry
2.4
Forward
7.6
More Details
73.6
P/E
P/E
Price to Earnings
73.6
vs History
9
vs Industry
6
Median 3Y
55.7
Median 5Y
55.3
Industry
23.4
Forward
67.1
More Details
42.1
P/OCF
P/OCF
Price to OCF
42.1
vs History
38
vs Industry
9
Median 3Y
39.3
Median 5Y
39.6
Industry
15.5
More Details
1 104.7
P/FCFE
P/FCFE
Price to FCFE
1 104.7
vs History
1
vs Industry
0
Median 3Y
49.7
Median 5Y
55.1
Industry
23.2
More Details
8.8
P/B
P/B
Price to Book Value
8.8
vs History
65
vs Industry
8
Median 3Y
8.5
Median 5Y
12
Industry
2.3
More Details
7.9
EV/S
EV/S
Enterprise Value to Sales
7.9
vs History
44
vs Industry
16
Median 3Y
7.5
Median 5Y
7.7
Industry
2.5
Forward
7.6
More Details
10
EV/GP
EV/GP
Enterprise Value to Gross Profit
10
vs History
47
vs Industry
23
Median 3Y
9.6
Median 5Y
9.9
Industry
5.3
More Details
33.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.9
vs History
38
vs Industry
8
Median 3Y
30.9
Median 5Y
30.9
Industry
12.6
Forward
31.7
More Details
50.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
50.7
vs History
7
vs Industry
7
Median 3Y
40.7
Median 5Y
39.6
Industry
17.2
Forward
46.8
More Details
42.1
EV/OCF
EV/OCF
Enterprise Value to OCF
42.1
vs History
34
vs Industry
9
Median 3Y
38.8
Median 5Y
39.3
Industry
15.3
More Details
53.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
53.5
vs History
28
vs Industry
9
Median 3Y
46.6
Median 5Y
47.9
Industry
19.8
More Details
7
EV/IC
EV/IC
Enterprise Value to IC
7
vs History
61
vs Industry
12
Median 3Y
6.6
Median 5Y
12.2
Industry
2
More Details

Multiples Across Competitors

METROPOLIS Competitors Multiples
Metropolis Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Metropolis Healthcare Ltd
NSE:METROPOLIS
91.9B INR 7.9 73.6 33.9 50.7
US
Cigna Corp
NYSE:CI
98B USD 0.5 27.1 9.8 12.9
US
Cigna Group
XMUN:CGN
90.8B EUR 0.5 27 9.7 12.9
US
CVS Health Corp
NYSE:CVS
70.6B USD 0.2 9.6 8.7 8.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR 0.7 -26.7 10.1 22.7
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.1 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD 1.6 18 10.7 14.5
DE
Fresenius Medical Care AG
XMUN:FME
11.5B EUR 0.6 23 6.9 16.3
US
DaVita Inc
NYSE:DVA
12.1B USD 1 14.8 8.3 11.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
METROPOLIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
METROPOLIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
METROPOLIS stock valuation using valuation multiples.
Wall Street Estimates
METROPOLIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
METROPOLIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.